Semin intervent Radiol 2020; 37(05): 537-542
Yttrium-90 Radiation Segmentectomy
Guy E. Johnson
1
Section of Interventional Radiology, Department of Radiology, University of Washington, Seattle, Washington
,
Siddharth A. Padia
2
Section of Interventional Radiology, Department of Radiology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
› Author Affiliations
References
1
Kennedy A,
Nag S,
Salem R.
et al.
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 68 (01) 13-23
2
Riaz A,
Gates VL,
Atassi B.
et al.
Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys 2011; 79 (01) 163-171
3
Marrero JA,
Kulik LM,
Sirlin CB.
et al.
Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018; 68 (02) 723-750
4
Padia SA,
Lewandowski RJ,
Johnson GE.
et al;
Society of Interventional Radiology Standards of Practice Committee.
Radioembolization of hepatic malignancies: background, quality improvement guidelines, and future directions. J Vasc Interv Radiol 2017; 28 (01) 1-15
5
Lewandowski RJ,
Kulik LM,
Riaz A.
et al.
A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009; 9 (08) 1920-1928
6
Zori AG,
Ismael MN,
Limaye AR.
et al.
Locoregional therapy protocols with and without radioembolization for hepatocellular carcinoma as bridge to liver transplantation. Am J Clin Oncol 2020; 43 (05) 325-333
7
Gabr A,
Kulik L,
Mouli S.
et al.
Liver transplantation following yttrium-90 radioembolization: 15-year experience in 207-patient cohort. Hepatology 2020; ; (epub ahead of print)
8
Liu B,
Long J,
Wang W.
et al.
Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study. BMC Cancer 2019; 19 (01) 699
9
Nishigaki Y,
Tomita E,
Hayashi H.
et al.
Efficacy and safety of radiofrequency ablation for hepatocellular carcinoma in the caudate lobe of the liver. Hepatol Res 2013; 43 (05) 467-474
10
Labgaa I,
Tabrizian P,
Titano J.
et al.
Feasibility and safety of liver transplantation or resection after transarterial radioembolization with yttrium-90 for unresectable hepatocellular carcinoma. HPB (Oxford) 2019; 21 (11) 1497-1504
11
Louie JD,
Kothary N,
Kuo WT.
et al.
Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol 2009; 20 (05) 606-613
12
Song YS,
Paeng JC,
Kim HC.
et al.
PET/CT-based dosimetry in 90 Y-microsphere selective internal radiation therapy: single cohort comparison with pretreatment planning on (99m)Tc-MAA imaging and correlation with treatment efficacy. Medicine (Baltimore) 2015; 94 (23) e945
13
Kappadath SC,
Mikell J,
Balagopal A,
Baladandayuthapani V,
Kaseb A,
Mahvash A.
Hepatocellular carcinoma tumor dose response after 90 Y-radioembolization with glass microspheres using 90 Y-SPECT/CT-based voxel dosimetry. Int J Radiat Oncol Biol Phys 2018; 102 (02) 451-461
14
Vouche M,
Habib A,
Ward TJ.
et al.
Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology 2014; 60 (01) 192-201
15
Chan KT,
Alessio AM,
Johnson GE.
et al.
Prospective trial using internal pair-production positron emission tomography to establish the yttrium-90 radioembolization dose required for response of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2018; 101 (02) 358-365
16
Garin E,
Lenoir L,
Rolland Y.
et al.
Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med 2012; 53 (02) 255-263
17
Garin E,
Rolland Y,
Edeline J.
et al.
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis. J Nucl Med 2015; 56 (03) 339-346
18
Garin E,
Tzelikas L,
Guiu B.
et al.
Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: final overall survival analysis of a multicenter randomized phase II study (DOSISPHERE-01). J Clin Oncol 2020; 38 (4 suppl): 516
19
Salem R,
Padia SA,
Lam M.
et al.
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging 2019; 46 (08) 1695-1704
20
Gabr A,
Riaz A,
Johnson GE.
et al.
Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants. Eur J Nucl Med Mol Imaging 2020; ; (epub ahead of print)
21
Padia SA,
Johnson GE,
Horton KJ.
et al.
Segmental yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study. J Vasc Interv Radiol 2017; 28 (06) 777-785.e1
22
Biederman DM,
Titano JJ,
Korff RA.
et al.
Radiation segmentectomy versus selective chemoembolization in the treatment of early-stage hepatocellular carcinoma. J Vasc Interv Radiol 2018; 29 (01) 30-37.e2
23
Biederman DM,
Titano JJ,
Bishay VL.
et al.
Radiation segmentectomy versus TACE combined with microwave ablation for unresectable solitary hepatocellular carcinoma up to 3 cm: a propensity score matching study. Radiology 2017; 283 (03) 895-905
24
Lewandowski RJ,
Gabr A,
Abouchaleh N.
et al.
Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma. Radiology 2018; 287 (03) 1050-1058
25
Meiers C,
Taylor A,
Geller B,
Toskich B.
Safety and initial efficacy of radiation segmentectomy for the treatment of hepatic metastases. J Gastrointest Oncol 2018; 9 (02) 311-315
26
Padia SA,
Johnson GE,
Agopian VG.
et al.
Yttrium-90 radiation segmentectomy for hepatic metastases: A multi-institutional study of safety and efficacy. J Surg Oncol 2020; 1-7 . Online ahead of print.
27
Padia SA,
Kwan SW,
Roudsari B,
Monsky WL,
Coveler A,
Harris WP.
Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity. J Vasc Interv Radiol 2014; 25 (07) 1067-1073
